ABBV vs ABT
By Alex · Tickerpine
AbbVie Inc. vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | ABT |
|---|---|---|
| Price | $265.79 | $116.13 |
| Market cap | $469.68B | $200.95B |
| P/E ratio | 74.7 | 37.7 |
| ROE | — | 10.58% |
| Profit margin | 9.80% | 11.65% |
| Revenue growth | 10.20% | 13.00% |
| Dividend yield | 2.62% | 2.16% |
| Beta | 0.28 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs ABT in plain English
- ABBV is the bigger company — about 2.3× the market cap of ABT.
- ABT is cheaper on earnings (P/E 37.7 vs 74.7).
- ABT is growing revenue faster (13% vs 10%).
- ABBV has the higher dividend yield (2.62% vs 2.16%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.